AU1872900A - Chemical compounds - Google Patents
Chemical compoundsInfo
- Publication number
- AU1872900A AU1872900A AU18729/00A AU1872900A AU1872900A AU 1872900 A AU1872900 A AU 1872900A AU 18729/00 A AU18729/00 A AU 18729/00A AU 1872900 A AU1872900 A AU 1872900A AU 1872900 A AU1872900 A AU 1872900A
- Authority
- AU
- Australia
- Prior art keywords
- chemical compounds
- compounds
- chemical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98403279 | 1998-12-23 | ||
| EP98403281 | 1998-12-23 | ||
| EP98403280 | 1998-12-23 | ||
| EP98403280 | 1998-12-23 | ||
| EP98403281 | 1998-12-23 | ||
| EP98403279 | 1998-12-23 | ||
| EP99400297 | 1999-02-09 | ||
| EP99400297 | 1999-02-09 | ||
| PCT/GB1999/004308 WO2000039716A2 (en) | 1998-12-23 | 1999-12-17 | Arylpropenylimidazoles as farnesyl-protein transferase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1872900A true AU1872900A (en) | 2000-07-31 |
Family
ID=27443752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU18729/00A Abandoned AU1872900A (en) | 1998-12-23 | 1999-12-17 | Chemical compounds |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US6486156B1 (en) |
| EP (1) | EP1140858A2 (en) |
| JP (1) | JP2002533476A (en) |
| AU (1) | AU1872900A (en) |
| WO (1) | WO2000039716A2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9930317D0 (en) | 1999-12-22 | 2000-02-09 | Zeneca Ltd | Novel compounds |
| WO2005046683A1 (en) * | 2003-10-07 | 2005-05-26 | Renovis, Inc. | Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| BRPI0606365A2 (en) * | 2005-02-28 | 2017-06-27 | Renovis Inc | compound or a pharmaceutically acceptable salt, solvate or prodrug thereof and stereoisomers and tautomers thereof, pharmaceutical composition, methods for preventing, treating, ameliorating or controlling a disease or condition and for preparing a compound, use of a compound or a salt , solvate or pharmaceutically acceptable composition thereof, method of treating a mammal, and, combination |
| US7576099B2 (en) | 2005-02-28 | 2009-08-18 | Renovis, Inc. | Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2069481B (en) * | 1980-02-13 | 1983-07-27 | Farmos Oy | Substituted imidazole derivatives |
| WO1996030015A1 (en) * | 1995-03-29 | 1996-10-03 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| WO1997017070A1 (en) * | 1995-11-06 | 1997-05-15 | University Of Pittsburgh | Inhibitors of protein isoprenyl transferases |
| AU5772698A (en) | 1997-01-29 | 1998-08-18 | Zeneca Limited | Inhibitors of farnesyl protein transferase |
| CA2281598A1 (en) * | 1997-02-21 | 1998-08-27 | Tetsuya Aono | Fused ring compounds, process for producing the same and use thereof |
| WO1999020612A1 (en) * | 1997-10-22 | 1999-04-29 | Astrazeneca Uk Limited | Imidazole derivatives and their use as farnesyl protein transferase inhibitors |
| DE69801590T2 (en) | 1997-10-22 | 2002-07-11 | Astrazeneca Ab, Soedertaelje | IMIDAZOLE DERIVATIVES AND THEIR USE AS FARNESYL PROTEIN TRANSFERASE INHIBITORS |
-
1999
- 1999-12-17 US US09/869,064 patent/US6486156B1/en not_active Expired - Fee Related
- 1999-12-17 WO PCT/GB1999/004308 patent/WO2000039716A2/en not_active Ceased
- 1999-12-17 JP JP2000591543A patent/JP2002533476A/en not_active Withdrawn
- 1999-12-17 AU AU18729/00A patent/AU1872900A/en not_active Abandoned
- 1999-12-17 EP EP99962358A patent/EP1140858A2/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US6486156B1 (en) | 2002-11-26 |
| EP1140858A2 (en) | 2001-10-10 |
| WO2000039716A2 (en) | 2000-07-06 |
| JP2002533476A (en) | 2002-10-08 |
| WO2000039716A3 (en) | 2001-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2093597A (en) | Chemical compounds | |
| GB9800428D0 (en) | Chemical compounds | |
| GB9812709D0 (en) | Chemical compounds | |
| GB9811159D0 (en) | Chemical compounds | |
| AU5052199A (en) | Chemical compounds | |
| AU5637499A (en) | Chemical compounds iii | |
| AU1424200A (en) | Compounds | |
| GB9812088D0 (en) | Chemical compounds | |
| AU4501699A (en) | Aminoazole compounds | |
| GB9804343D0 (en) | Chemical compounds | |
| AU6104599A (en) | Chemical compounds viii | |
| GB9804861D0 (en) | Chemical compounds | |
| AU1434500A (en) | Compounds | |
| AU1872900A (en) | Chemical compounds | |
| AU5050899A (en) | Chemical compounds | |
| GB9801812D0 (en) | Chemical compounds | |
| AU5661399A (en) | Compounds | |
| GB9802028D0 (en) | Chemical compounds | |
| AU5689400A (en) | Chemical compounds | |
| AU3715899A (en) | Di-peroxy compounds | |
| GB9809161D0 (en) | Chemical compounds | |
| AUPP298598A0 (en) | Neurologically-active compounds | |
| AUPP499898A0 (en) | Chemical methods | |
| GB9803169D0 (en) | Chemical compounds | |
| GB9807579D0 (en) | Chemical compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |